Navigation Links
Oxford University Press enters publishing partnership with Infectious Diseases Society of America

Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID). Oxford Journals will assume publication of both journals from 1st of January, 2011.

IDSA's twice monthly publications are an excellent fit with Oxford Journals' strong medicine collection, which includes complementary titles in the field of infectious diseases, as well as with OUP's clinical book publishing program.

"Oxford University Press's academic orientation and its emphasis on scientific rigor complement the mission of IDSA," said Richard J. Whitley, MD, FIDSA, president of IDSA. "Our two organizations are committed to the dissemination of scientific knowledge."

Clinical Infectious Diseases, one of the most heavily cited journals in the field, publishes articles on infectious diseases, microbiology, hospital infections, public health, and HIV/AIDS. In 2009 this journal was named one of the "100 Most Influential Journals in Biology and Medicine" of the past 100 years by the Special Libraries Association. CID is edited by Sherwood L. Gorbach, MD, FIDSA.

Founded in 1904, the Journal of Infectious Diseases predates the Society's formation in 1963 and is the premier publication for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms. JID is edited by Martin S. Hirsch, MD, FIDSA.

Nigel Portwood, Chief Executive of Oxford University Press, commented: "The IDSA journals are highly prestigious and internationally renowned so the IDSA quite rightly require their publishing partner to deliver the best services available in the industry. The fact that OUP has been chosen to fulfil that requirement is something I and my colleagues are very excited and proud about."


Contact: Catarina Walsh
Oxford University Press

Related biology news :

1. UMMS and CIW grant key RNAi rights to Oxford Biomedica
2. U. Mass Medical School and Carnegie announce licensing agreements with Oxford BioMedica
3. Oxford Journals and the International Society for Computational Biology announce new partnership
4. Oxfords Dr. Rosalind Rickaby receives 2009 Rosenstiel Award
5. Oxford University Press launches new librarian newsletter
6. A study by the MUHC and McGill University opens a new door to understanding cancer
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. Bioengineers at University of Pennsylvania devise nanoscale system to measure cellular forces
10. Binghamton University researchers investigate evolving malaria resistance
11. Antioxidant to retard wrinkles discovered by Hebrew University researcher
Post Your Comments:
(Date:11/9/2015)... Calif. , Nov. 9, 2015  Synaptics Inc. ... interface solutions, today announced broader entry into the automotive ... solutions that match the pace of consumer electronics human ... biometric sensors are ideal for the automotive industry and ... Europe , ...
(Date:10/29/2015)... Oct. 29, 2015   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Association (MHTA) as one of only three finalists for ... – Small and Growing" category. The Tekne Awards honor ... shown superior technology innovation and leadership. ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ... it has closed the sale of its global contrast ... NYSE Euronext) in a transaction valued at approximately $270 ... and a total of approximately 1,000 employees spread across ... St. Louis area. This entire workforce and ...
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/26/2015)... England , November 26, 2015 ... innovative medical device company specializing in imaging technologies, announced today ... European Commission as part of the Horizon 2020 European Union ... carry out a large-scale clinical trial in breast cancer. ... (Logo: , --> --> ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
Breaking Biology Technology: